Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up

Glutaric acidemia IIc

MONDO:0700076

Any multiple acyl-CoA dehydrogenase deficiency in which the cause of the disease is a mutation in the ETFDH gene.

Also known as: ETFDH deficiency, GA2C, glutaric acidemia 2C, multiple acyl-CoA dehydrogenase deficiency caused by mutation in ETFDH

20 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Broader categories

Cardiovascular disorder (1051) Disease (680) Heart disorder (300) Metabolic disease (233) Musculoskeletal system disorder (207) Inherited lipid metabolism disorder (189) Hereditary disease (176) Cardiomyopathy (144) Hypertrophic cardiomyopathy (112) Inborn mitochondrial metabolism disorder (58)
Trials to join now! 10 Not yet recruiting 1 Not yet finished but already full! 6 Completed 2 Terminated 1
Sort by
  • New drug aims to tame hard-to-control seizures in rare mitochondrial disorders

    Disease control Terminated

    This study tested a drug called vatiquinone in 68 people with mitochondrial disease and epilepsy that doesn't respond to standard treatments. Participants were randomly assigned to receive either vatiquinone or a placebo for 24 weeks to see if the drug could reduce the number of …

    Phase: PHASE2, PHASE3 • Sponsor: PTC Therapeutics • Aim: Disease control

    Last updated Jun 27, 2026 12:03 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space